AAP
NEO icon

Ardsley Advisory Partners’s NeoGenomics NEO Stock Holding History

Ardsley Advisory Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15,000
Closed -$118K – 173
2015
Q4 		$118K Buy
+15,000
New +$110K 0.02% 138

Other funds holding NEO

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Ardsley Advisory Partners's NEO Position: Q1 2016 in Review

Ardsley Advisory Partners sold out of NeoGenomics (NEO) in Q1 2016, closing a stake of 15,000 shares — an estimated $118K sold.

Ardsley Advisory Partners first reported a position in NEO in Q4 2015 and held it in 1 quarter. The position peaked at $118K in Q4 2015. 119 funds tracked by Wall St. Rank hold NEO as of Q1 2016.

  • Ardsley Advisory Partners reported no remaining NeoGenomics position as of Q1 2016 after selling out during the quarter.
  • Ardsley Advisory Partners sold 15,000 NeoGenomics shares in Q1 2016, an estimated $118K.
  • Ardsley Advisory Partners first reported a position in NeoGenomics in Q4 2015 and held it in 1 quarter.
  • Ardsley Advisory Partners's NeoGenomics position peaked at $118K in Q4 2015.
  • 119 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2016.

Based on Ardsley Advisory Partners's 13F filing for Q1 2016, filed 16 May 2016.